Regulatory timelines suggest more effective oral options are on the horizon
Diabetes 59 , 17651770 (2010)
Glucagon & Energy Expenditure Glucagon receptor activation: Evaluated for effects on hepatic glucose output, lipid handling, and energy expenditure in animal models
Unlike BPC-157, which has been in the Canadian market for years and is relatively difficult to fake because the market norms are well-established, retatrutide is newer
Simple recipes and healthy eating tips included
As we experience new therapies that come to market at continuously rising costs, we must be good stewards of our member premium dollars that are used to pay for these therapies, explains Tiffany Liesmann, Chief Pharmacist at Blue Cross and Blue Shield of Kansas